Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Thibault

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Surgery|July 27, 1999
Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutritionS Chan, K C McCowen, B R Bistrian, et al.
Molecular Therapy. Methods & Clinical Development|September 9, 2016
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editingArnold Park, Patrick Hong, Sohui T Won, et al.
Neurobiology of Disease|May 26, 2022
Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis modelsCole D Libner, Hannah E Salapa, Catherine Hutchinson, et al.
Plos Pathogens|October 9, 2020
Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticitySatoshi Ikegame, Shannon M Beaty, Christian Stevens, et al.
Tumori|June 10, 1998
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancerA Thibault, W D Figg, R C Bergan, et al.
Pharmacotherapy|November 1, 1993
Anaphylactoid reaction with suraminA Thibault, W D Figg, M R Cooper, et al.
Anti-Cancer Drugs|June 1, 1994
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrateW D Figg, R G Walls, M R Cooper, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 9, 2024
Dysfunctional RNA binding protein induced neurodegeneration is attenuated by inhibition of the integrated stress responseJoseph-Patrick W E Clarke, Miranda L Messmer, Jacob Pilon, et al.
Cancer|April 15, 1995
A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancerW D Figg, A Thibault, M R Cooper, et al.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Surgery|July 27, 1999
Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutritionS Chan, K C McCowen, B R Bistrian, et al.
Molecular Therapy. Methods & Clinical Development|September 9, 2016
Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editingArnold Park, Patrick Hong, Sohui T Won, et al.
Neurobiology of Disease|May 26, 2022
Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis modelsCole D Libner, Hannah E Salapa, Catherine Hutchinson, et al.
Plos Pathogens|October 9, 2020
Genome-wide transposon mutagenesis of paramyxoviruses reveals constraints on genomic plasticitySatoshi Ikegame, Shannon M Beaty, Christian Stevens, et al.
Tumori|June 10, 1998
A phase II study of 5-aza-2'deoxycytidine (decitabine) in hormone independent metastatic (D2) prostate cancerA Thibault, W D Figg, R C Bergan, et al.
Pharmacotherapy|November 1, 1993
Anaphylactoid reaction with suraminA Thibault, W D Figg, M R Cooper, et al.
Anti-Cancer Drugs|June 1, 1994
In vitro antitumor effect of hydroxyurea on hormone-refractory prostate cancer cells and its potentiation by phenylbutyrateW D Figg, R G Walls, M R Cooper, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 9, 2024
Dysfunctional RNA binding protein induced neurodegeneration is attenuated by inhibition of the integrated stress responseJoseph-Patrick W E Clarke, Miranda L Messmer, Jacob Pilon, et al.
Cancer|April 15, 1995
A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancerW D Figg, A Thibault, M R Cooper, et al.
The Prostate|September 1, 1996
The differentiating agent phenylacetate increases prostate-specific antigen production by prostate cancer cellsR Walls, A Thibault, L Liu, et al.
Pageof 8